Biologics for rheumatoid arthritis: an overview of Cochrane reviews
about
Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritisLiver involvement in subjects with rheumatic diseaseSubcutaneous or intramuscular methotrexate for rheumatoid arthritisAyurveda interventions for rheumatoid arthritisSelf-management education programmes for rheumatoid arthritisDown-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activityExercise therapy for the rheumatoid handInterventions for periodontal disease in people with rheumatoid arthritisOfatumumab for rheumatoid arthritisEtanercept for the treatment of rheumatoid arthritisAdverse effects of biologics: a network meta-analysis and Cochrane overviewTNF-alpha inhibitors for juvenile idiopathic arthritisBiologic interventions for fatigue in rheumatoid arthritisMethotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysisDendritic Cell-based Immunotherapy for Rheumatoid Arthritis: from Bench to Bedside2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritisEffect of Methotrexate Plus Adalimumab on the Achievement of Rheumatoid Arthritis Therapeutic Goals: Post Hoc Analysis of Japanese Patients (MELODY Study).Cost effectiveness of different treatment strategies in the treatment of patients with moderate to severe rheumatoid arthritis in chinaComparative persistence of the TNF antagonists in rheumatoid arthritis--a population-based cohort studyBiologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.The safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis.What guidance is available for researchers conducting overviews of reviews of healthcare interventions? A scoping review and qualitative metasummary.Experiences of mobility for people living with rheumatoid arthritis who are receiving biologic drug therapy: implications for podiatry services.Big data and systematic reviews in nutritional epidemiology.Methodology in conducting a systematic review of systematic reviews of healthcare interventionsEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugsThe perplexity of prescribing and switching of biologic drugs in rheumatoid arthritis: a UK regional audit of practiceInsights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study.Interpreting trial results following use of different intention-to-treat approaches for preventing attrition bias: a meta-epidemiological study protocol.The use of anti-TNFα medications for rheumatologic disease in pregnancy.The treatment strategies of autoimmune disease may need a different approach from conventional protocol: a review.Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?Abatacept treatment for rheumatoid arthritisApplying science in practice: the optimization of biological therapy in rheumatoid arthritis.Blockade of TNF-α rapidly inhibits pain responses in the central nervous system.The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agentsLabour induction with prostaglandins: a systematic review and network meta-analysis.Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection.Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitors¹H-NMR-Based Metabolomic Study for Identifying Serum Profiles Associated with the Response to Etanercept in Patients with Rheumatoid Arthritis.
P2860
Q21134808-74921C3C-994B-4A02-BE96-C8F4F5A96CFAQ22000839-6953B947-2540-45E0-B8E0-84CD933E69FBQ24187565-0369AB23-31D0-4CD0-BA07-1390D42E1A87Q24187687-91224B3F-5C63-4B0A-B05B-6F03865B737EQ24193309-6DB8EB89-8392-4ECF-88BC-32430BA01301Q24193435-B714BC9E-0DE1-4638-B0A0-2573B190EE72Q24200886-1ABADEA3-7F81-4CA2-BB6A-C52E1C00A656Q24200961-050D018B-53C1-4311-9AC8-AEC733EBD205Q24202719-F2BC5046-4CF9-4C22-8CCA-2D86FD927F82Q24202751-74717610-26C1-42D8-956E-EA92C9D669A6Q24234197-97091455-DE4F-4A88-B8DA-F46BABAC08D1Q24234429-38ECFFCA-7356-4FF0-BBA4-3BE6DCB447A7Q26471538-0E727114-767A-4A06-A5BF-A08DEB6F1AD2Q26751187-5EA65B6B-4874-48DE-8CDF-372D5AEEE815Q26764858-F5585DEC-8B5A-4B3C-BD3A-D7C08BB00DA7Q26828418-FB214C89-946B-446D-B5A7-60014483C7A8Q27335031-CD50E4B1-7C0E-44C8-A095-2127319B4C69Q28484306-DB30F0DB-2269-4714-BD12-014196CCF997Q28542423-6BA2D232-4BAA-493E-ADE4-367759094544Q30234528-1C2BAF0D-3255-4231-8A8B-13A8BD103C9AQ30397234-25D6043C-D24F-41B9-8C3A-FBA4DC0FB42FQ30828711-FBEAA126-7966-49DC-AB92-02410199FE64Q30842186-E571F91B-E3A2-43C2-9EAC-85CE0A766D15Q30870465-1B62B4A2-FCAE-467E-9396-8D8718867568Q33811344-E25A3D16-E8A0-4D4F-8FB6-703E06BB1F87Q34110066-FF76BA3C-260F-44AB-8000-4C2A6F67CE37Q34184710-7C611A67-CB07-425E-A0C7-BC1F5EBB39F4Q34237578-FA26923C-AE8B-4F3D-87D2-32871E42494AQ34264322-59550B0F-2D39-41DF-8E0D-34FF85C230C6Q34272138-77CBDF59-E71C-41A0-93F9-609B1EDBA9CCQ34318285-931B687B-21EA-42A3-AFEF-17442D3F3239Q34338355-A7EA3453-AF39-4582-8F26-D732CDB67C52Q34588972-19F843A6-EBEE-4DE0-A047-45EAD9FAB94AQ34613898-692D4694-4B75-4348-A3B0-3E0DB5190E24Q34621522-6730FE99-FB80-4516-9D5F-37E2B2A13BB3Q35082559-97BF3D7A-ED93-4533-B0F0-AF4D00F2FA5FQ35158202-FD14F6E9-3990-4539-B32C-94EA8662974CQ35572441-E5EA5F5D-9F04-4A3B-8C3F-820378347B27Q35620336-DEA6BB64-8949-40D0-A48B-031A365F4CA0Q35838512-D3A2957E-7E6F-4B8A-AE92-8F149042BF31
P2860
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
@ast
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
@en
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
@en-gb
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
@nl
type
label
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
@ast
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
@en
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
@en-gb
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
@nl
prefLabel
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
@ast
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
@en
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
@en-gb
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
@nl
P2093
P2860
P50
P3181
P1476
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
@en
P2093
George A Wells
Jasvinder A Singh
Maria E Suarez-Almazor
Robin Christensen
P2860
P3181
P356
10.1002/14651858.CD007848.PUB2
P577
2009-10-07T00:00:00Z